• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中异常的酪蛋白激酶II

Aberrant casein kinase II in Alzheimer's disease.

作者信息

Iimoto D S, Masliah E, DeTeresa R, Terry R D, Saitoh T

机构信息

University of California, San Diego, School of Medicine, La Jolla, CA 92093.

出版信息

Brain Res. 1990 Jan 22;507(2):273-80. doi: 10.1016/0006-8993(90)90282-g.

DOI:10.1016/0006-8993(90)90282-g
PMID:2337767
Abstract

Abnormal protein phosphorylation has been identified in Alzheimer's disease (AD) for several proteins including a Mr 60,000 protein, a Mr 86,000 protein and a microtubule-associated protein tau. The Mr 86,000 protein is phosphorylated by protein kinase C, whereas protein kinases responsible for other aberrant phosphorylation reactions are not known. In addition to protein kinase C, another kinase, casein kinase II (CK-II), has now been shown to be aberrant in AD. The spermine-dependent CK-II activity is reduced by 84% in AD and the amount of CK-II as determined by its immunoreactivity on a Western blot is reduced by 63%. Furthermore, the distribution of CK-II in AD is altered. Although the neuronal cell body reacts well with CK-II antisera in the normal cortex, the non-tangle-bearing neurons in the AD cortex showed a 15-30% decrease in anti-CK-II immunoreactivity. The neurofibrillary tangles, on the other hand, stain very strongly with rabbit anti-CK-II and indicates that CK-II may be involved in the pathology of AD. The study of CK-II immunoreactivity for dementing diseases other than AD revealed a similar reduction, suggesting the CK-II involvement in the common process of neurodegeneration.

摘要

在阿尔茨海默病(AD)中已发现几种蛋白质存在异常的蛋白质磷酸化,包括一种分子量为60,000的蛋白质、一种分子量为86,000的蛋白质和一种微管相关蛋白tau。分子量为86,000的蛋白质被蛋白激酶C磷酸化,而负责其他异常磷酸化反应的蛋白激酶尚不清楚。除蛋白激酶C外,另一种激酶——酪蛋白激酶II(CK-II),现已证明在AD中也存在异常。在AD中,精胺依赖性CK-II活性降低了84%,通过蛋白质免疫印迹法测定的CK-II量减少了63%。此外,AD中CK-II的分布也发生了改变。虽然在正常皮质中神经元细胞体与CK-II抗血清反应良好,但AD皮质中无神经缠结的神经元抗CK-II免疫反应性降低了15%-30%。另一方面,神经原纤维缠结用兔抗CK-II染色非常强烈,表明CK-II可能参与了AD的病理过程。对除AD以外的痴呆疾病的CK-II免疫反应性研究显示出类似的降低,提示CK-II参与了神经退行性变的共同过程。

相似文献

1
Aberrant casein kinase II in Alzheimer's disease.阿尔茨海默病中异常的酪蛋白激酶II
Brain Res. 1990 Jan 22;507(2):273-80. doi: 10.1016/0006-8993(90)90282-g.
2
Aberrant protein phosphorylation and cytoarchitecture in Alzheimer's disease.阿尔茨海默病中的异常蛋白质磷酸化和细胞结构
Prog Clin Biol Res. 1989;317:769-80.
3
Amyloid beta-protein stimulates casein kinase I and casein kinase II activities.淀粉样β蛋白刺激酪蛋白激酶I和酪蛋白激酶II的活性。
Brain Res. 1993 Nov 26;629(1):47-52. doi: 10.1016/0006-8993(93)90479-7.
4
Phosphorylation of tau protein by casein kinase-1 converts it to an abnormal Alzheimer-like state.酪蛋白激酶-1对tau蛋白的磷酸化作用将其转化为异常的阿尔茨海默氏样状态。
J Neurochem. 1995 Mar;64(3):1420-3. doi: 10.1046/j.1471-4159.1995.64031420.x.
5
Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.磷酸化丝裂原活化蛋白激酶(MAPK/ERK-P)、38 kDa蛋白激酶(p38-P)、应激激活蛋白激酶(SAPK/JNK-P)和钙/钙调蛋白依赖性激酶II(CaM激酶II)在tau蛋白病的神经元和神经胶质细胞的tau沉积物中差异表达。
J Neural Transm (Vienna). 2001;108(12):1397-415. doi: 10.1007/s007020100016.
6
Changes in protein kinases in brain aging and Alzheimer's disease. Implications for drug therapy.脑衰老和阿尔茨海默病中蛋白激酶的变化。对药物治疗的启示。
Drugs Aging. 1995 Feb;6(2):136-49. doi: 10.2165/00002512-199506020-00006.
7
S6 kinase phosphorylated at T229 is involved in tau and actin pathologies in Alzheimer's disease.在T229位点磷酸化的S6激酶参与阿尔茨海默病中的tau蛋白和肌动蛋白病变。
Neuropathology. 2016 Aug;36(4):325-32. doi: 10.1111/neup.12275. Epub 2015 Nov 18.
8
Casein kinase II alteration precedes tau accumulation in tangle formation.酪蛋白激酶II的改变在缠结形成中tau蛋白积累之前就已出现。
Am J Pathol. 1992 Feb;140(2):263-8.
9
Casein kinase II is associated with neurofibrillary tangles but is not an intrinsic component of paired helical filaments.酪蛋白激酶II与神经原纤维缠结有关,但不是双螺旋丝的固有成分。
Brain Res. 1992 Feb 21;573(1):126-32. doi: 10.1016/0006-8993(92)90121-o.
10
Hippocampal neurons predisposed to neurofibrillary tangle formation are enriched in type II calcium/calmodulin-dependent protein kinase.易发生神经原纤维缠结的海马神经元富含II型钙/钙调蛋白依赖性蛋白激酶。
J Neuropathol Exp Neurol. 1990 Jan;49(1):49-63. doi: 10.1097/00005072-199001000-00006.

引用本文的文献

1
Protein kinase CK2α' as a dual modulator of neuroimmune signaling and synaptic dysfunction in Tauopathy.蛋白激酶CK2α'作为Tau蛋白病中神经免疫信号和突触功能障碍的双重调节因子。
Res Sq. 2025 Aug 7:rs.3.rs-7078069. doi: 10.21203/rs.3.rs-7078069/v1.
2
Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ-Induced Neurotoxicity in Differentiated SH-SY5Y Cells.橙皮苷和CK2抑制剂DRB对分化的SH-SY5Y细胞中Aβ诱导的神经毒性的神经保护作用
Mol Neurobiol. 2025 May 30. doi: 10.1007/s12035-025-05082-2.
3
Review of FUNDC1-mediated mitochondrial autophagy in Alzheimer's disease.
阿尔茨海默病中FUNDC1介导的线粒体自噬研究综述
Front Aging Neurosci. 2025 May 12;17:1544241. doi: 10.3389/fnagi.2025.1544241. eCollection 2025.
4
Molecular mechanisms and consequences of TDP-43 phosphorylation in neurodegeneration.神经退行性变中TDP - 43磷酸化的分子机制及后果
Mol Neurodegener. 2025 May 8;20(1):53. doi: 10.1186/s13024-025-00839-8.
5
Structure-Activity Relationship Studies of Tetracyclic Pyrrolocarbazoles Inhibiting Heterotetrameric Protein Kinase CK2.抑制异源四聚体蛋白激酶CK2的四环吡咯并咔唑的构效关系研究
Molecules. 2024 Dec 27;30(1):63. doi: 10.3390/molecules30010063.
6
CK and LRRK2 Involvement in Neurodegenerative Diseases.CK 和 LRRK2 参与神经退行性疾病。
Int J Mol Sci. 2024 Oct 30;25(21):11661. doi: 10.3390/ijms252111661.
7
Effect of histidine protonation state on ligand binding at the ATP-binding site of human protein kinase CK2.组氨酸质子化状态对人蛋白激酶 CK2 的 ATP 结合位点配体结合的影响。
Sci Rep. 2024 Jan 17;14(1):1463. doi: 10.1038/s41598-024-51905-y.
8
Protein Kinases and their Inhibitors Implications in Modulating Disease Progression.蛋白激酶及其抑制剂对疾病进展调控的影响
Protein J. 2023 Dec;42(6):621-632. doi: 10.1007/s10930-023-10159-9. Epub 2023 Sep 28.
9
Casein Kinase 2 Affects Epilepsy by Regulating Ion Channels: A Potential Mechanism.酪蛋白激酶 2 通过调节离子通道影响癫痫:一种潜在的机制。
CNS Neurol Disord Drug Targets. 2024;23(7):894-905. doi: 10.2174/1871527322666230622124618.
10
Phosphorylation and Dephosphorylation of Beta-Amyloid Peptide in Model Cell Cultures: The Role of Cellular Protein Kinases and Phosphatases.模型细胞培养中β-淀粉样肽的磷酸化与去磷酸化:细胞蛋白激酶和磷酸酶的作用
Life (Basel). 2023 Jan 4;13(1):147. doi: 10.3390/life13010147.